US6605712B1
(en)
|
1990-12-20 |
2003-08-12 |
Arch Development Corporation |
Gene transcription and ionizing radiation: methods and compositions
|
AU1328595A
(en)
*
|
1994-06-20 |
1996-01-15 |
Auckland Uniservices Limited |
Brain damage monitor
|
GB9524968D0
(en)
*
|
1995-12-06 |
1996-02-07 |
Brown Brian H |
Impedance pneumography
|
AU6230298A
(en)
*
|
1997-02-24 |
1998-09-09 |
Tanita Corporation |
Living body impedance measuring instrument and body composition measuring instrument
|
ES2142219B1
(es)
*
|
1997-03-06 |
2000-11-16 |
Nte Sa |
Procedimiento para determinar la composicion y calidad de sustancias de naturaleza carnica.
|
ES2151774B1
(es)
*
|
1997-03-06 |
2001-07-01 |
Nte Sa |
Aparato y procedimiento para la medida de volumenes y composicion corporal global y segmental en seres humanos.
|
ES2143911B1
(es)
*
|
1997-03-06 |
2000-12-01 |
Nte Sa |
Metodo y aparato para medir la concentracion y composicion de biomasa.
|
JP3125730B2
(ja)
*
|
1997-09-11 |
2001-01-22 |
憲一 山越 |
血行動態表示装置
|
US6153811A
(en)
|
1997-12-22 |
2000-11-28 |
Dekalb Genetics Corporation |
Method for reduction of transgene copy number
|
US6125297A
(en)
*
|
1998-02-06 |
2000-09-26 |
The United States Of America As Represented By The United States National Aeronautics And Space Administration |
Body fluids monitor
|
US6122544A
(en)
*
|
1998-05-01 |
2000-09-19 |
Organ; Leslie William |
Electrical impedance method and apparatus for detecting and diagnosing diseases
|
US6307123B1
(en)
|
1998-05-18 |
2001-10-23 |
Dekalb Genetics Corporation |
Methods and compositions for transgene identification
|
US6429357B1
(en)
|
1999-05-14 |
2002-08-06 |
Dekalb Genetics Corp. |
Rice actin 2 promoter and intron and methods for use thereof
|
AUPQ113799A0
(en)
*
|
1999-06-22 |
1999-07-15 |
University Of Queensland, The |
A method and device for measuring lymphoedema
|
US6387671B1
(en)
*
|
1999-07-21 |
2002-05-14 |
The Regents Of The University Of California |
Electrical impedance tomography to control electroporation
|
EP1217942A1
(en)
|
1999-09-24 |
2002-07-03 |
Healthetech, Inc. |
Physiological monitor and associated computation, display and communication unit
|
JP3705574B2
(ja)
*
|
1999-09-30 |
2005-10-12 |
株式会社タニタ |
生体電気インピーダンス測定装置
|
US7499745B2
(en)
*
|
2000-02-28 |
2009-03-03 |
Barbara Ann Karmanos Cancer Institute |
Multidimensional bioelectrical tissue analyzer
|
US6482158B2
(en)
|
2000-05-19 |
2002-11-19 |
Healthetech, Inc. |
System and method of ultrasonic mammography
|
US6607387B2
(en)
|
2000-10-30 |
2003-08-19 |
Healthetech, Inc. |
Sensor system for diagnosing dental conditions
|
AU2002218496A1
(en)
*
|
2000-11-29 |
2002-06-11 |
Art Haven 9 Co., Ltd. |
Method and device for measuring body compositions
|
US6768921B2
(en)
*
|
2000-12-28 |
2004-07-27 |
Z-Tech (Canada) Inc. |
Electrical impedance method and apparatus for detecting and diagnosing diseases
|
FI109651B
(fi)
|
2001-03-23 |
2002-09-30 |
Delfin Technologies Ltd |
Menetelmä kudosturvotuksen mittaamiseksi
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
ES2184609B1
(es)
*
|
2001-04-27 |
2004-06-16 |
Nte S.A. |
Metodo y aparato de obtencion de caracteristicas fisicas y/o quimicas de un medio biologico.
|
EP1399541A4
(en)
|
2001-05-22 |
2005-04-13 |
Univ Chicago |
RNA POLYMERASE DEPENDENT ON SINGLE VIBRATION N4 DNA
|
IL143374A0
(en)
*
|
2001-05-24 |
2002-04-21 |
Transscan Medical Ltd |
Anomaly detection based on signal variations
|
WO2002100247A2
(en)
*
|
2001-06-13 |
2002-12-19 |
Ckm Diagnostics, Inc. |
Non-invasive method and apparatus for tissue detection
|
MXPA04003944A
(es)
|
2001-10-26 |
2004-07-08 |
Baylor College Medicine |
Una composicion y metodo para alterar la masa corporal fina y propiedades oseas en un sujeto.
|
MY142457A
(en)
|
2001-12-11 |
2010-11-30 |
Advisys Inc |
Plasmid mediated supplementation for treating chronically ill subjects
|
US8211031B2
(en)
*
|
2002-01-15 |
2012-07-03 |
Orsan Medical Technologies Ltd. |
Non-invasive intracranial monitor
|
AU2003209608A1
(en)
|
2002-01-15 |
2003-07-30 |
Orsan Medical Equipment Ltd. |
Device for monitoring blood flow to brain
|
US7998080B2
(en)
*
|
2002-01-15 |
2011-08-16 |
Orsan Medical Technologies Ltd. |
Method for monitoring blood flow to brain
|
JP4105472B2
(ja)
*
|
2002-04-12 |
2008-06-25 |
株式会社フィジオン |
身体組成測定装置
|
CA2486559C
(en)
|
2002-05-22 |
2015-07-21 |
Monsanto Technology Llc |
Fatty acid desaturases from fungi
|
AU2003304195B8
(en)
|
2002-07-15 |
2008-08-28 |
Board Of Regents, The University Of Texas System |
Combinatorial protein library screening by periplasmic expression
|
JP4796299B2
(ja)
|
2002-08-12 |
2011-10-19 |
ジェンネレックス インコーポレイティッド |
ポックスウイルスおよび癌に関する方法および組成物
|
AU2002951925A0
(en)
*
|
2002-10-09 |
2002-10-24 |
Queensland University Of Technology |
An Impedence Cardiography Device
|
US20030126593A1
(en)
*
|
2002-11-04 |
2003-07-03 |
Mault James R. |
Interactive physiological monitoring system
|
WO2004073641A2
(en)
|
2003-02-18 |
2004-09-02 |
Kevin Slawin |
Induced activation in dendritic cells
|
US20060264775A1
(en)
*
|
2003-03-14 |
2006-11-23 |
Mills Gary N |
Methods of and apparatus for determining fluid volume presence in mammalian tissue
|
EP1615551B1
(en)
|
2003-04-15 |
2016-06-08 |
Philips Intellectual Property & Standards GmbH |
Device and method for examination and use of an electrical field in an object under examination containing magnetic particles
|
DE10339084B4
(de)
|
2003-08-26 |
2015-10-29 |
Drägerwerk AG & Co. KGaA |
Elektroimpedanztomographie-Gerät
|
CN101926647B
(zh)
*
|
2003-09-12 |
2013-06-05 |
肾脏研究所有限公司 |
生物阻抗方法和仪器
|
US20080076998A1
(en)
*
|
2003-12-01 |
2008-03-27 |
Z-Tech (Canada) Inc. |
Breast electrode array and method of analysis for detecting and diagnosing diseases
|
US7330032B2
(en)
*
|
2003-12-30 |
2008-02-12 |
The Mitre Corporation |
Techniques for building-scale electrostatic tomography
|
WO2005122888A1
(en)
|
2004-06-18 |
2005-12-29 |
The University Of Queensland |
Oedema detection
|
US8068906B2
(en)
|
2004-06-21 |
2011-11-29 |
Aorora Technologies Pty Ltd |
Cardiac monitoring system
|
JP4904263B2
(ja)
|
2004-07-15 |
2012-03-28 |
オーサン メディカル テクノロジーズ リミテッド |
脳灌流監視装置
|
WO2006044868A1
(en)
*
|
2004-10-20 |
2006-04-27 |
Nervonix, Inc. |
An active electrode, bio-impedance based, tissue discrimination system and methods and use
|
US20060085048A1
(en)
*
|
2004-10-20 |
2006-04-20 |
Nervonix, Inc. |
Algorithms for an active electrode, bioimpedance-based tissue discrimination system
|
EP2281889B1
(en)
|
2004-11-12 |
2014-07-30 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
EP1827222A1
(en)
|
2004-11-26 |
2007-09-05 |
Z-Tech (Canada) Inc. |
Weighted gradient method and system for diagnosing disease
|
US8109981B2
(en)
*
|
2005-01-25 |
2012-02-07 |
Valam Corporation |
Optical therapies and devices
|
DE102005022896B3
(de)
*
|
2005-05-18 |
2006-05-11 |
Dräger Medical AG & Co. KG |
Vorrichtung und Verfahren zur Steuerung eines Beatmungsgerätes
|
CA2613524C
(en)
*
|
2005-07-01 |
2015-12-29 |
Impedance Cardiology Systems Inc. |
Pulmonary monitoring system
|
EP1898784B1
(en)
|
2005-07-01 |
2016-05-18 |
Impedimed Limited |
Method and apparatus for performing impedance measurements
|
EP1898782B1
(en)
|
2005-07-01 |
2016-04-06 |
Impedimed Limited |
Monitoring system
|
EP1909642A1
(en)
*
|
2005-07-20 |
2008-04-16 |
Impedance Cardiology Systems Inc. |
Index determination
|
US8099250B2
(en)
*
|
2005-08-02 |
2012-01-17 |
Impedimed Limited |
Impedance parameter values
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
WO2007030668A2
(en)
|
2005-09-07 |
2007-03-15 |
Jennerex Biotherapeutics Ulc |
Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses
|
US9724012B2
(en)
|
2005-10-11 |
2017-08-08 |
Impedimed Limited |
Hydration status monitoring
|
US20090317421A1
(en)
|
2006-01-18 |
2009-12-24 |
Dominique Missiakas |
Compositions and methods related to staphylococcal bacterium proteins
|
US7794404B1
(en)
|
2006-03-31 |
2010-09-14 |
Pacesetter, Inc |
System and method for estimating cardiac pressure using parameters derived from impedance signals detected by an implantable medical device
|
US8600497B1
(en)
*
|
2006-03-31 |
2013-12-03 |
Pacesetter, Inc. |
Systems and methods to monitor and treat heart failure conditions
|
US8761870B2
(en)
*
|
2006-05-30 |
2014-06-24 |
Impedimed Limited |
Impedance measurements
|
AU2007278864A1
(en)
|
2006-07-27 |
2008-01-31 |
Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Cellular receptor for antiproliferative factor
|
WO2009016433A2
(en)
|
2006-09-15 |
2009-02-05 |
Ottawa Health Research Institute |
Oncolytic rhabdovirus
|
CA3058450A1
(en)
|
2006-10-19 |
2008-04-24 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
CN101617039A
(zh)
|
2006-10-20 |
2009-12-30 |
代表亚利桑那大学的亚利桑那校董会 |
经修饰的蓝细菌
|
AU2007327573B2
(en)
|
2006-11-30 |
2013-07-18 |
Impedimed Limited |
Measurement apparatus
|
ATE555128T1
(de)
|
2006-11-30 |
2012-05-15 |
Res Dev Foundation |
Verbesserte immunglobulin-bibliotheken
|
JP5400618B2
(ja)
*
|
2007-01-15 |
2014-01-29 |
インぺディメッド リミテッド |
モニタリングシステム
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
WO2008119166A1
(en)
*
|
2007-03-30 |
2008-10-09 |
Z-Tech (Canada) Inc. |
Active guarding for reduction of resistive and capactive signal loading with adjustable control of compensation level
|
US8504153B2
(en)
|
2007-04-04 |
2013-08-06 |
Pacesetter, Inc. |
System and method for estimating cardiac pressure based on cardiac electrical conduction delays using an implantable medical device
|
US8208999B2
(en)
|
2007-04-04 |
2012-06-26 |
Pacesetter, Inc. |
System and method for estimating electrical conduction delays from immittance values measured using an implantable medical device
|
WO2008128281A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Impedimed Limited |
Monitoring system and probe
|
EP2155789B1
(en)
|
2007-05-01 |
2013-07-24 |
Research Development Foundation |
Immunoglobulin fc libraries
|
US7596411B1
(en)
|
2007-06-08 |
2009-09-29 |
Pacesetter, Inc. |
Apparatus and method for two-component bioelectrical impedance ratio measuring and monitoring
|
AU2008286194B2
(en)
*
|
2007-08-09 |
2014-05-15 |
Impedimed Limited |
Impedance measurement process
|
WO2009029831A1
(en)
|
2007-08-31 |
2009-03-05 |
University Of Chicago |
Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
|
US8836345B2
(en)
*
|
2007-11-05 |
2014-09-16 |
Impedimed Limited |
Impedance determination
|
WO2009102509A2
(en)
|
2008-01-10 |
2009-08-20 |
Research Development Foundation |
Vaccines and diagnostics for the ehrlichioses
|
MX2010008168A
(es)
|
2008-01-25 |
2011-02-24 |
P53 Inc |
Biomarcadores p53.
|
EP2247238B1
(en)
*
|
2008-01-29 |
2013-10-23 |
St. Jude Medical AB |
Mplantable medical device (imd) for monitoring permeability status of cell membranes.
|
AU2008207672B2
(en)
*
|
2008-02-15 |
2013-10-31 |
Impedimed Limited |
Impedance Analysis
|
ES2587395T3
(es)
|
2008-06-04 |
2016-10-24 |
Cellular Dynamics International, Inc. |
Procedimientos para la producción de células IPS usando un enfoque no vírico
|
CN107988261A
(zh)
|
2008-08-12 |
2018-05-04 |
细胞动力国际有限公司 |
产生ips细胞的方法
|
WO2010022089A2
(en)
|
2008-08-18 |
2010-02-25 |
University Of Maryland, Baltimore |
Derivatives of apf and methods of use
|
EP3238739B1
(en)
|
2008-09-22 |
2020-10-21 |
Baylor College of Medicine |
Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
|
CN102333540B
(zh)
|
2008-10-06 |
2015-04-22 |
芝加哥大学 |
与细菌eap、emp和/或adsa蛋白相关的组合物和方法
|
JP2012505010A
(ja)
*
|
2008-10-07 |
2012-03-01 |
オルサン メディカル テクノロジーズ リミテッド |
脳血行動態パラメータの測定
|
GB0820309D0
(en)
*
|
2008-11-06 |
2008-12-17 |
Middlesex University Higher Ed |
Detection of cancer
|
US9615766B2
(en)
|
2008-11-28 |
2017-04-11 |
Impedimed Limited |
Impedance measurement process
|
EP2370568B1
(en)
|
2008-12-10 |
2017-07-19 |
Dana-Farber Cancer Institute, Inc. |
Mek mutations conferring resistance to mek inhibitors
|
US8492133B2
(en)
|
2009-01-20 |
2013-07-23 |
Ramot At Tel Aviv University, Ltd. |
MIR-21 promoter driven targeted cancer therapy
|
WO2010096510A2
(en)
|
2009-02-17 |
2010-08-26 |
Edenspace Systems Corporation |
Tempering of cellulosic biomass
|
US8764672B2
(en)
*
|
2009-02-17 |
2014-07-01 |
Preston K. Manwaring |
System, method and device for monitoring the condition of an internal organ
|
BRPI1010307B1
(pt)
|
2009-04-03 |
2021-07-27 |
University Of Chicago |
Polipeptídeos variantes de proteína a (spa), composição imunogênica compreendendo os mesmos, vacina, método de produção da referida vacina, bem como uso dos referidos polipeptídeos
|
US8748381B2
(en)
|
2009-04-28 |
2014-06-10 |
Vanderbilt University |
Compositions and methods for the treatment of disorders involving epithelial cell apoptosis
|
WO2010138971A1
(en)
|
2009-05-29 |
2010-12-02 |
Edenspace Systems Corporation |
Plant gene regulatory elements
|
WO2010141801A2
(en)
|
2009-06-05 |
2010-12-09 |
Cellular Dynamics International, Inc. |
Reprogramming t cells and hematophietic cells
|
EP2470653A1
(en)
|
2009-08-26 |
2012-07-04 |
Research Development Foundation |
Methods for creating antibody libraries
|
DK2477499T3
(en)
|
2009-09-14 |
2018-06-06 |
Sillajen Biotherapeutics Inc |
COMBINATION CANCER THERAPY WITH ONCOLYTIC VACCINIA VIRUS
|
US8937214B2
(en)
|
2009-10-23 |
2015-01-20 |
Monsanto Technology Llc |
Methods and compositions for expression of transgenes in plants
|
JP5643829B2
(ja)
|
2009-10-26 |
2014-12-17 |
インぺディメッド リミテッドImpedimed Limited |
インピーダンス測定の分析において用いるための方法及び装置
|
AU2010321683B2
(en)
|
2009-11-18 |
2014-06-26 |
Impedimed Limited |
Signal distribution for patient-electrode measurements
|
CN102858959B
(zh)
|
2009-12-10 |
2016-02-24 |
渥太华医院研究院 |
溶瘤弹状病毒
|
US10080799B2
(en)
|
2010-02-12 |
2018-09-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
CA2789696C
(en)
|
2010-02-25 |
2017-11-07 |
Dana-Farber Cancer Institute, Inc. |
Braf mutations conferring resistance to braf inhibitors
|
EP3214174B1
(en)
|
2010-03-04 |
2019-10-16 |
InteRNA Technologies B.V. |
A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt
|
KR20120139767A
(ko)
|
2010-03-09 |
2012-12-27 |
더 브로드 인스티튜트, 인코퍼레이티드 |
1차 암 요법에 대한 저항성을 갖는 또는 발달시키는 환자에서 암을 진단 및 치료하는 방법
|
JP2013523818A
(ja)
|
2010-04-05 |
2013-06-17 |
ザ・ユニバーシティー・オブ・シカゴ |
免疫反応のエンハンサーとしてのプロテインA(SpA)抗体に関連する組成物および方法
|
WO2011126976A1
(en)
|
2010-04-07 |
2011-10-13 |
Vanderbilt University |
Reovirus vaccines and methods of use therefor
|
EP2560672B1
(en)
|
2010-04-19 |
2014-03-05 |
Research Development Foundation |
Rtef-1 variants and uses thereof
|
US20110289625A1
(en)
|
2010-05-19 |
2011-11-24 |
Rujin Chen |
Altered leaf morphology and enhanced agronomic properties in plants
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
WO2011156588A1
(en)
|
2010-06-09 |
2011-12-15 |
Dana-Farber Cancer Institute, Inc. |
A mek 1 mutation conferring resistance to raf and mek inhibitors
|
AU2011267849B2
(en)
|
2010-06-15 |
2015-02-05 |
FUJIFILM Cellular Dynamics, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
EP2582793B1
(en)
|
2010-06-15 |
2017-09-06 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
CN103037885B
(zh)
|
2010-07-02 |
2015-08-26 |
芝加哥大学 |
与蛋白A(SpA)变体相关的组合物和方法
|
EP3369817A1
(en)
|
2010-07-06 |
2018-09-05 |
InteRNA Technologies B.V. |
Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma , or in diseases or conditions with activated braf pathway
|
WO2012006440A2
(en)
|
2010-07-07 |
2012-01-12 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
JP5936218B2
(ja)
|
2010-08-04 |
2016-06-22 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
不死化b細胞のリプログラミング
|
WO2012034067A1
(en)
|
2010-09-09 |
2012-03-15 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens
|
US9084746B2
(en)
|
2010-09-22 |
2015-07-21 |
The Regents Of The University Of Colorado, A Body Corporate |
Therapeutic applications of SMAD7
|
WO2012061615A1
(en)
|
2010-11-03 |
2012-05-10 |
The Samuel Roberts Noble Foundation, Inc. |
Transcription factors for modification of lignin content in plants
|
KR101942237B1
(ko)
|
2011-01-04 |
2019-01-25 |
신라젠(주) |
종양 항원에 대한 항체의 생산 및 종양용해 우두 바이러스의 투여에 의한 종양 특이적 보체 의존적 세포독성의 생산
|
EP2474617A1
(en)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
Mir for treating neo-angiogenesis
|
US8952132B2
(en)
|
2011-02-07 |
2015-02-10 |
Research Development Foundation |
Engineered immunoglobulin FC polypeptides
|
EP2673358B1
(en)
|
2011-02-08 |
2019-01-09 |
FUJIFILM Cellular Dynamics, Inc. |
Hematopoietic precursor cell production by programming
|
US9307918B2
(en)
|
2011-02-09 |
2016-04-12 |
Orsan Medical Technologies Ltd. |
Devices and methods for monitoring cerebral hemodynamic conditions
|
EP3406628A1
(en)
|
2011-04-08 |
2018-11-28 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
ES2627529T3
(es)
|
2011-06-08 |
2017-07-28 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Composiciones para tratamiento de glioblastoma
|
EP2732029B1
(en)
|
2011-07-11 |
2019-01-16 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for cell reprogramming and genome engineering
|
JP6317670B2
(ja)
|
2011-08-15 |
2018-04-25 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
ブドウ球菌プロテインaに対する抗体に関連した組成物および方法
|
WO2013026015A1
(en)
|
2011-08-18 |
2013-02-21 |
Dana-Farber Cancer Institute, Inc. |
Muc1 ligand traps for use in treating cancers
|
US9273102B2
(en)
|
2011-10-12 |
2016-03-01 |
Niels Iversen Møller |
Peptides derived from Campylobacter jejuni and their use in vaccination
|
AU2012351988B2
(en)
|
2011-12-14 |
2017-05-04 |
Impedimed Limited |
Devices, systems and methods for determining the relative spatial change in subsurface resistivities across frequencies in tissue
|
EP3369818B1
(en)
|
2011-12-22 |
2021-06-09 |
InteRNA Technologies B.V. |
Mirna for treating head and neck cancer
|
BR112014019894A8
(pt)
*
|
2012-02-15 |
2017-07-11 |
Koninklijke Philips Nv |
Sistema e método de espectrografia de bioimpedância, e, programa de computador
|
CA2910320A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus disease
|
US9968668B2
(en)
|
2012-04-26 |
2018-05-15 |
The University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
BR112015002295B1
(pt)
|
2012-07-31 |
2022-02-01 |
The Board Of Regents Of The University Of Texas System |
Método para induzir a formação de célula beta in vitro
|
EP2897454B1
(en)
|
2012-09-24 |
2019-11-06 |
Seminis Vegetable Seeds, Inc. |
Methods and compositions for extending shelf life of plant products
|
US9890216B2
(en)
|
2012-10-23 |
2018-02-13 |
Board Of Regents, The University Of Texas System |
Antibodies with engineered IgG Fc domains
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
RU2684211C2
(ru)
|
2013-02-21 |
2019-04-04 |
Тёрнстоун Лимитед Партнершип |
Композиция вакцины
|
AU2014218807A1
(en)
|
2013-02-22 |
2015-09-03 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
DE102013203177A1
(de)
|
2013-02-26 |
2014-08-28 |
Hamilton Medical Ag |
System zur automatisierten Einstellung eines durch eine Beatmungseinrichtung vorgegebenen Drucks
|
EP2961386B1
(en)
|
2013-02-28 |
2019-07-10 |
The General Hospital Corporation |
Mirna profiling compositions and methods of use
|
WO2014132137A2
(en)
|
2013-03-01 |
2014-09-04 |
Université De Genève |
Transgenic cell selection
|
JP6576251B2
(ja)
|
2013-03-08 |
2019-09-18 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate |
PTD−Smad7薬物療法
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
CA2905352A1
(en)
|
2013-03-14 |
2014-09-25 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling t cell proliferation
|
EP3004329B1
(en)
|
2013-06-05 |
2020-03-04 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
CN105636614A
(zh)
|
2013-09-09 |
2016-06-01 |
菲格内有限责任公司 |
用于软骨细胞或软骨型细胞再生的基因治疗
|
CA2929555A1
(en)
|
2013-11-08 |
2015-05-14 |
Baylor Research Institute |
Nuclear localization of glp-1 stimulates myocardial regeneration and reverses heart failure
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
WO2015082536A1
(en)
|
2013-12-03 |
2015-06-11 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
CN106132992B
(zh)
|
2014-01-29 |
2020-08-07 |
达娜-法勃肿瘤研究所公司 |
针对muc1-c/胞外结构域(muc1-c/ecd)的抗体
|
CA2937750A1
(en)
|
2014-02-14 |
2015-08-20 |
Bellicum Pharmaceuticals, Inc. |
Methods for activating t cells using an inducible chimeric polypeptide
|
WO2015123561A2
(en)
|
2014-02-14 |
2015-08-20 |
University Of Utah Research Foundation |
Methods and compositions for inhibiting retinopathy of prematurity
|
CA2940765A1
(en)
|
2014-02-25 |
2015-09-03 |
Research Development Foundation |
Sty peptides for inhibition of angiogenesis
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
CA2959168A1
(en)
|
2014-09-02 |
2016-03-10 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by myd88 and cd40 polypeptides
|
EP3215522B1
(en)
|
2014-11-03 |
2021-12-01 |
Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum |
T cell receptors directed against bob1 and uses thereof
|
WO2016075305A2
(en)
|
2014-11-13 |
2016-05-19 |
Evaxion Biotech Aps |
Peptides derived from acinetobacter baumannii and their use in vaccination
|
EP3234145B1
(en)
|
2014-12-15 |
2019-06-05 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlled activation or elimination of therapeutic cells
|
WO2016113252A2
(en)
|
2015-01-12 |
2016-07-21 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting klebsiella pneumoniae
|
WO2016120697A1
(en)
|
2015-01-28 |
2016-08-04 |
Sabic Global Technologies B.V. |
Methods and compositions for high-efficiency production of biofuel and/or biomass
|
US10457737B2
(en)
|
2015-02-09 |
2019-10-29 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
US11421229B2
(en)
|
2015-02-20 |
2022-08-23 |
Baylor College Of Medicine |
p63 inactivation for the treatment of heart failure
|
US20160263155A1
(en)
|
2015-03-10 |
2016-09-15 |
Leiden University Medical Center |
T cell receptors directed against the preferentially expressed antigen of melanoma and uses thereof
|
US20180201656A1
(en)
|
2015-07-04 |
2018-07-19 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Pseudomonas Aeruginosa
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
KR102669318B1
(ko)
|
2015-10-20 |
2024-05-28 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
유전자 프로그래밍에 의한 다중-계통 조혈 전구 세포 생산
|
CN108463548B
(zh)
|
2015-10-30 |
2023-04-18 |
加利福尼亚大学董事会 |
由干细胞产生t细胞的方法及使用所述t细胞的免疫治疗方法
|
EP3370733B1
(en)
|
2015-11-02 |
2021-07-14 |
Board of Regents, The University of Texas System |
Methods of cd40 activation and immune checkpoint blockade
|
US20190038713A1
(en)
|
2015-11-07 |
2019-02-07 |
Multivir Inc. |
Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
CA3004438A1
(en)
|
2015-11-09 |
2017-05-18 |
The Children's Hospital Of Philadelphia |
Glypican 2 as a cancer marker and therapeutic target
|
GB2545703B
(en)
|
2015-12-22 |
2019-01-09 |
Univ Sheffield |
Apparatus and methods for determining force applied to the tip of a probe
|
WO2017144523A1
(en)
|
2016-02-22 |
2017-08-31 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
CA3019635A1
(en)
|
2016-03-31 |
2017-10-05 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
WO2017216384A1
(en)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination targeting ichthyophthirius multifiliis
|
WO2017220787A1
(en)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccines against aearomonas salmonicida infection
|
EP3478325B1
(en)
|
2016-07-01 |
2024-07-17 |
Research Development Foundation |
Elimination of proliferating cells from stem cell-derived grafts
|
EP3487872A1
(en)
|
2016-07-22 |
2019-05-29 |
Evaxion Biotech ApS |
Chimeric proteins for inducing immunity towards infection with s. aureus
|
WO2018035429A1
(en)
|
2016-08-18 |
2018-02-22 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of vla-4 and igf-1r
|
JP2019530440A
(ja)
|
2016-09-02 |
2019-10-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
インターロイキン6受容体α結合単鎖可変断片を含む方法および組成物
|
IL265810B2
(en)
|
2016-10-05 |
2024-08-01 |
Fujifilm Cellular Dynamics Inc |
A method for the direct separation of pluripotent stem cells into homozygous HLA cells of the immune system
|
JP7248571B2
(ja)
|
2016-10-05 |
2023-03-29 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
MeCP2が破壊された誘導多能性幹細胞からの成熟系列の生成
|
JP2020510624A
(ja)
|
2016-12-12 |
2020-04-09 |
マルチビア インコーポレイテッド |
がんおよび感染性疾患の治療および予防のための、ウイルス遺伝子治療および免疫チェックポイント阻害剤を含む方法および組成物
|
WO2018127545A1
(en)
|
2017-01-05 |
2018-07-12 |
Evaxion Biotech Aps |
Vaccines targeting pseudomonas aeruginosa
|
SG11201909331UA
(en)
|
2017-04-18 |
2019-11-28 |
Fujifilm Cellular Dynamics Inc |
Antigen-specific immune effector cells
|
EP3621988A1
(en)
|
2017-05-09 |
2020-03-18 |
Bellicum Pharmaceuticals, Inc. |
Methods to augment or alter signal transduction
|
CA3079524A1
(en)
|
2017-11-03 |
2019-05-09 |
Interna Technologies B.V. |
Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
WO2019099493A1
(en)
|
2017-11-14 |
2019-05-23 |
Henry Ford Health System |
Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury
|
RU2020124404A
(ru)
|
2018-01-05 |
2022-01-24 |
Оттава Хоспитл Рисерч Инститьют |
Векторы на основе модифицированного вируса осповакцины
|
WO2019145399A1
(en)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccines for prophylaxis of s. aureus infections
|
US20210094991A1
(en)
|
2018-03-19 |
2021-04-01 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancer
|
JP2021519587A
(ja)
|
2018-03-30 |
2021-08-12 |
ユニバーシティ オブ ジュネーブ |
マイクロrna発現構築物及びその使用
|
US20220000932A1
(en)
|
2018-09-28 |
2022-01-06 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
EP3870207A1
(en)
|
2018-10-22 |
2021-09-01 |
Evaxion Biotech ApS |
Vaccines targeting m. catharrhalis
|
WO2020171889A1
(en)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocking lipid accumulation or inflammation in thyroid eye disease
|
EP3931206A1
(en)
|
2019-02-27 |
2022-01-05 |
Evaxion Biotech ApS |
Vaccines targeting h. influenzae
|
WO2020212756A2
(en)
|
2019-04-18 |
2020-10-22 |
Genkin Dmitry Dmitrievich |
Reprogramming of polymorphonuclear leukocytes
|
JP2022541538A
(ja)
|
2019-07-19 |
2022-09-26 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
グリピカン2結合ドメインを含有するキメラ抗原受容体
|
CN115175680A
(zh)
|
2019-10-18 |
2022-10-11 |
加利福尼亚大学董事会 |
Plxdc激活剂及其用于治疗血管病症的用途
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
EP4087593A1
(en)
|
2020-01-06 |
2022-11-16 |
Evaxion Biotech A/S |
Vaccines targeting neisseria gonorrhoeae
|
US20230242643A1
(en)
|
2020-05-27 |
2023-08-03 |
Antion Biosciences Sa |
Adapter molecules to re-direct car t cells to an antigen of interest
|
US20230201267A1
(en)
|
2020-05-29 |
2023-06-29 |
FUJIFILM Cellular Dynamics, Inc. |
Retinal pigmented epithelium and photoreceptor dual cell aggregates and methods of use thereof
|
EP4157865A1
(en)
|
2020-05-29 |
2023-04-05 |
FUJIFILM Cellular Dynamics, Inc. |
Bilayer of retinal pigmented epithelium and photoreceptors and use thereof
|
TW202241935A
(zh)
|
2020-12-18 |
2022-11-01 |
美商世紀治療股份有限公司 |
具有可調適受體專一性之嵌合抗原受體系統
|
WO2022173767A1
(en)
|
2021-02-09 |
2022-08-18 |
University Of Houston System |
Oncolytic virus for systemic delivery and enhanced anti-tumor activities
|
US20240122865A1
(en)
|
2021-02-19 |
2024-04-18 |
Pfizer Inc. |
Methods of Protecting RNA
|
KR20230167397A
(ko)
|
2021-04-08 |
2023-12-08 |
얀센 바이오테크 인코포레이티드 |
향상된 줄기 세포 유사 기억 t 세포 조작을 위한 물질 및 방법
|
CA3216719A1
(en)
|
2021-05-03 |
2022-11-10 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature corneal endothelial cells
|
TW202309268A
(zh)
|
2021-05-07 |
2023-03-01 |
安斯泰來再生醫藥協會 |
產生成熟肝細胞的方法
|
KR20240011831A
(ko)
|
2021-05-26 |
2024-01-26 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
만능 줄기 세포에서 유전자의 신속한 사일런싱을 방지하기 위한 방법
|
JP2024526293A
(ja)
|
2021-07-05 |
2024-07-17 |
エヴァクシオン・バイオテック・アクティエセルスカブ |
淋菌を標的とするワクチン
|
WO2023081813A1
(en)
|
2021-11-05 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Zip cytokine receptors
|
WO2023081894A2
(en)
|
2021-11-08 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Pre-effector car-t cell gene signatures
|
WO2023089556A1
(en)
|
2021-11-22 |
2023-05-25 |
Pfizer Inc. |
Reducing risk of antigen mimicry in immunogenic medicaments
|
GB2614309A
(en)
|
2021-12-24 |
2023-07-05 |
Stratosvir Ltd |
Improved vaccinia virus vectors
|
WO2023144779A1
(en)
|
2022-01-28 |
2023-08-03 |
Pfizer Inc. |
Coronavirus antigen variants
|
US20230295661A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
WO2023213393A1
(en)
|
2022-05-04 |
2023-11-09 |
Evaxion Biotech A/S |
Staphylococcal protein variants and truncates
|
WO2023240109A1
(en)
|
2022-06-07 |
2023-12-14 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules for modulating t-cell activity, and uses thereof
|
WO2023240182A1
(en)
|
2022-06-08 |
2023-12-14 |
St. Jude Children's Research Hospital, Inc. |
Disruption of kdm4a in t cells to enhance immunotherapy
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
US20240003871A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Cellular Dynamics, Inc. |
Ipsc-derived astrocytes and methods of use thereof
|
WO2024059787A1
(en)
|
2022-09-16 |
2024-03-21 |
St. Jude Children's Research Hospital, Inc. |
Disruption of asxl1 in t cells to enhance immunotherapy
|
WO2024130212A1
(en)
|
2022-12-16 |
2024-06-20 |
Turnstone Biologics Corp. |
Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors
|
WO2024186630A1
(en)
|
2023-03-03 |
2024-09-12 |
Henry Ford Health System |
Use of extracellular vesicles for the treatment of cancer
|